Marketing here lives inside real constraints: regulated claims, a scientific audience that demands evidence, and buyers whose decisions affect patients and research outcomes. XQL is built for that. We are specialists at marketing technical products to scientific and clinical buyers, turning clinical and scientific evidence, within the claims you are cleared to make, into credible positioning, compliant demand, and discoverability, tied to pipeline in your CRM. We do not make medical claims and we are not your regulatory authority; we run the evidence-based marketing in coordination with your regulatory and MLR review.
You can only say what your regulatory clearance, approval, or the evidence supports, and overstating efficacy or making an off-label or unsubstantiated claim is a genuine legal and regulatory risk, not just a marketing faux pas. Every claim may need medical, legal, and regulatory (MLR) review. Marketing has to be persuasive within those limits, compelling and evidence-anchored without overstepping, which most marketers have no framework for and which a careless agency can turn into a compliance problem.
Clinicians, scientists, and lab directors evaluate on peer-reviewed data, clinical validation, study design, and reproducibility, and they discount marketing language on sight. Credibility is earned with evidence, publications, validation data, real methodology, and the endorsement of respected peers, not with a campaign. A message that reads as promotional to a scientific audience actively erodes trust. Marketing has to speak the language of evidence and let the data lead.
A purchase can involve clinicians or researchers who use it, lab or department heads, procurement, IT and security for connected or software products, and sometimes payers and reimbursement. Each has different concerns, evidence expectations, and veto power, and the cycle is long and evidence-gated. Marketing tuned to one stakeholder stalls with another, and a generic funnel cannot navigate a decision that runs through clinical validation, budget cycles, and institutional approval.
For devices, diagnostics, and many digital-health products, whether and how the product is reimbursed, and how it moves through institutional procurement, can matter as much as the technology. A clinically superior product can lose to a reimbursement or budget reality. Marketing has to speak to the economic and access story, coverage, workflow fit, total cost, alongside the clinical one, because the people who approve spend weigh those as heavily as efficacy.
In a field where decisions affect patient outcomes and scientific validity, credibility and trust outweigh cleverness entirely. A hype-heavy campaign does not just underperform, it signals that you do not understand the seriousness of the work, and it repels the exact clinical and scientific buyers you need. What earns trust is rigor, evidence, transparency about limitations, and the endorsement of credible peers and institutions, built patiently and communicated soberly.
Clinicians, researchers, and lab buyers research through literature, specific technical and clinical queries, and increasingly AI assistants asked for options, evidence, or comparisons, and accuracy here is not optional, because a wrong or overstated AI answer about a medical product is a real problem. If you are not discoverable and accurately, compliantly represented where these buyers look, you are not considered, and if you are misrepresented, that is worse.
Let us be clear about the boundary, because in this field it is not optional. We do not make medical claims, we are not a clinical or regulatory authority, and we do not decide what is safe or effective, your evidence and your regulatory and MLR function do. What we do is run the evidence-based, compliant marketing, in close coordination with that function, so every claim is anchored to what you are cleared to say and nothing oversteps. We are also not clinicians or bench scientists, and we will not pretend to be. What we are is specialists in marketing technical products to scientific and technical buyers, across 9+ years and 60+ B2B tech companies. The medtech and life-science buyer is a demanding version of a familiar pattern: evidence-driven, skeptical of marketing, on a long, multi-stakeholder cycle, with the added weight of regulation, reimbursement, and the seriousness of patient and research outcomes. Our job is to learn your technology, your evidence, and your buyer's world fast through structured interviews with your team, respect the constraints, and make the clinical and scientific value legible and credible, within the claims you can make, to everyone who has to say yes and to the AI engines that now shape research. We show our full portfolio here, honestly labelled, and we bring that transferable system to the compliant, evidence-led side of medtech and life science rather than claiming clinical or regulatory credentials we do not hold.
A default stack built for a regulated, evidence-driven, multi-stakeholder market, run in coordination with your regulatory and MLR function. We adapt it to your product class, buyers, and constraints, but this is the shape that works when evidence and compliance lead.
Before spend, we build positioning anchored to your evidence and cleared claims, the clinical or scientific value, the workflow and economic fit, stated so a clinician, a scientist, a procurement lead, and, where relevant, a payer each believe it, and cleared through your MLR process. That evidence-anchored, compliance-cleared foundation is what lets everything downstream be both persuasive and safe.
We make your proof legible and accessible: publications and validation data, study summaries, KOL and institutional endorsement, and the access and economic story, presented soberly and within cleared claims. In this field these evidence assets are the marketing, and we develop and package them in coordination with your scientific and regulatory teams.
We make you discoverable and accurately represented where clinical and scientific buyers research, on the specific technical, clinical, and application queries they run, with evidence-led content that a rigorous reader trusts and that stays within cleared claims. It is the compounding base for the credibility a long, evidence-gated cycle needs.
Clinicians and researchers increasingly ask AI assistants for options and evidence, and accuracy is critical, a wrong AI answer about a medical product is a real problem. AI Search optimization builds the credible, accurate mentions and clean entity data the engines rely on, so you are represented correctly and within cleared claims. Across our work this drives roughly 80% AI Search recommendation success on the discoverable side.
Because clinicians, scientists, and institutions are won on evidence and peer trust, this is the core motion: KOL and scientific engagement, evidence-led thought leadership, presence at the conferences and journals where credibility forms, and account-based campaigns to target institutions and labs, all sober, evidence-anchored, and MLR-cleared.
We connect every touch to your CRM and track the long, multi-stakeholder path through clinical validation, reimbursement, and procurement, so activity is judged on qualified pipeline and revenue, not vanity metrics. Reporting answers which institutions and activities are advancing, which is how patience becomes defensible investment.
Strategy first, channels second, sales feedback always. We measure by the qualified demand and revenue we can trace back inside the CRM.
Our founder led their marketing as Head of Marketing, running a 7-person team across SEO, demand gen, and paid — $1M/year in marketing revenue. Re-engaged in 2026 and halved cost per MQL and SQL.
ServicesFractional CMO · SEO · Demand Generation · Paid Ads
Senior operators on every account. Never a junior pod.
Rebuilt inbound from scratch — 100% YoY SQL growth, 207% more traffic, domain rating from 12 to 45, and 141 articles shipped.
ServicesFractional CMO · SEO · Demand Generation
“We've seen a 207% increase in web traffic and our domain rating improved from 12 to 45.”
Took a referral-only firm to a real new-business engine — 5 deals and $240K revenue from Meta in a year, plus 2–4 SQLs/month from ChatGPT.
ServicesMeta Ads · Fractional CMO · AI Search
“Their expertise and proactiveness have impressed our team.”
Positioned them as the recommended Salesforce partner inside the major LLMs — two $1M enterprise deals closed from ChatGPT in a 3-month engagement.
ServicesAI Search · Fractional CMO · Meta Ads
“They operated with the discipline and initiative of an internal senior marketer.”
Built the marketing function from zero — website, SEO, paid, AI search — from 166 to 2,513 monthly clicks and 3 enterprise deals won.
ServicesFractional CMO · SEO · AI Search · Meta Ads
“They defined a clear marketing strategy and established our unique value proposition.”
Turned Salesforce-niche SEO into a deal channel — 2.73× traffic and MQL-to-SQL conversion up from 17% to 29%.
ServicesSEO · Content Marketing
“We have started receiving our first inbound requests.”
Restructured the marketing team and shifted to lead-driving SEO — doubling client count and growing SQLs 133% in nine months.
ServicesSEO · Fractional CMO
Switched them from brand-awareness content to lead-driving SEO — 20 of 25 service pages ranked top 5 and the first deals closed from organic.
ServicesSEO · Fractional CMO · Content Marketing
“XQL Group's marketing expertise is a hallmark of the engagement.”
Stood up SEO as a new acquisition channel — domain rating 27 to 44, 50+ leads, and 88 articles in nine months.
ServicesSEO
“Their subject matter expertise is highly impressive.”
After six months of zero results from another agency, we delivered +70% Google clicks and grew AI-assistant traffic from 10 to 154/month in three months — and the first SQLs from SEO.
ServicesSEO · AI Search
Meta appointment funnels at scale — 466 leads and over 100 booked sales conversations from a single paid channel.
ServicesAppointment Funnels · Meta Ads
“They've brought structure, strong execution, and constant initiative.”
Set up marketing from zero — positioning, website, LinkedIn social selling, and an ABM campaign that landed four new clients fast.
ServicesFractional CMO · ABM · LinkedIn
“Their ability to combine strategic vision with hands-on execution was particularly valuable.”
Positioned a small studio in a niche AI-search category — recommended by LLMs for 2 commercial keywords, landing a big client in one month.
ServicesAI Search · AEO/GEO · Website
“They knew how to approach AI search practically, not just in theory.”
Recommended by every major AI assistant for 3 commercial keywords, plus a deal closed from Meta appointment funnels.
ServicesAI Search · Appointment Funnels
“What impressed us most was their deep specialization with software development companies.”
Positioned for an important commercial keyword and recommended by the major AI assistants within a single month.
ServicesAI Search · AEO/GEO
Took over marketing as their agency after an unsuccessful in-house run — GTM strategy, paid funnels, AI search, and LinkedIn delivered 75 leads and the first qualified pipeline.
ServicesFractional CMO · GTM Strategy · Appointment Funnels · AI Search
A targeted ABM campaign booked 13 conversations with ICP accounts and opened three opportunities in two months.
ServicesABM
Repositioned the agency, revamped the site, and built appointment funnels that booked qualified intro calls at just $34 each.
ServicesAppointment Funnels · Positioning · Website
A custom AI-assistant paid funnel produced 76 leads and 34 booked appointments at $123 per call with an ICP.
ServicesAppointment Funnels · Meta Ads
Meta appointment funnels delivered 35 leads at a $42 CPL and closed two deals on modest spend.
ServicesAppointment Funnels · Meta Ads
The same standard applies to every market we work in: we measure marketing by qualified demand, accepted sales conversations, and revenue traced back to marketing inside the CRM.
Thanks to XQL Group's efforts, we've seen a 207% increase in web traffic and an improvement in domain rating from 12 to 45. The team has successfully optimized our SEO strategy and gained around 160 backlinks. Overall, they're responsive and thorough in their project management.
Since working with XQL Group, our domain rating has improved from 27 to 44. In addition, we've seen a 15% increase in monthly traffic within nine months. The team completes work on time and within the agreed budget. Moreover, their subject matter expertise is highly impressive.
XQL Group's efforts have resulted in 44 leads from paid campaigns and improved web traffic from Germany by 5x. The team is responsive, quickly surfaces issues, and communicates regularly through chats and virtual meetings. Their expertise and proactiveness have impressed our team.
Organic traffic has increased by 10–15% each month, and we have started receiving our first inbound requests. XQL Group's optimization tips have also helped improve keyword rankings, and internal stakeholders are impressed with the team's collaborative approach.
XQL Group has successfully defined a clear marketing strategy and established our company's unique value proposition. The team has also helped hire critical specialists for our marketing team. They are communicative and organized, and their expertise in the tech industry is impressive.
Thanks to XQL Group's efforts, we have defined our marketing strategy and hired key developers for our website. The team has launched retargeting campaigns on LinkedIn and developed a strong content marketing strategy. XQL Group's marketing expertise is a hallmark of the engagement.
They were not just talking about AI search in theory; they knew how to approach it practically.
What impressed us most was their deep specialization in working with software development companies.
They've brought structure, strong execution, and constant initiative to improve outcomes.
They operated with the discipline and initiative of an internal senior marketer.
Their ability to combine strategic vision with hands-on execution was particularly valuable.
Their focus on results and true interest in making things work set them apart.
XQL Group's project management was exemplary.
The quality of their work is consistently high.
It is a B2B marketing agency for the evidence-based, compliant side of medtech, biotech, and life-science tools companies, positioning, discoverability, credibility, and demand, all anchored to your evidence and the claims you are cleared to make. To be clear about the line: we do not make medical claims, we are not a clinical or regulatory authority, and we run everything in coordination with your regulatory and MLR function. We are specialists at marketing technical products to scientific and clinical buyers on long, evidence-gated cycles, and we tie it to revenue in your CRM.
By working compliance-first and in coordination with your regulatory and medical-legal-regulatory function. We anchor every claim to your clearances and evidence, build content designed to move through MLR review efficiently, and never overstate efficacy or stray off-label. We treat a claim as the regulated act it is, not a slogan. In a field where a careless claim is a real legal and regulatory risk, that disciplined, MLR-aware process is the foundation of the engagement, and it is what separates us from a generic agency that does not know the constraint exists.
No, and we will tell you so plainly. We are not clinicians, bench scientists, or a regulatory authority, and we do not decide what is safe, effective, or approvable, your evidence and your regulatory and MLR function do. What we bring is expertise in marketing technical products to skeptical, evidence-driven scientific and clinical buyers, applied within your constraints and in coordination with your experts. We make your evidence and value legible and credible; we do not generate or judge the science.
By leading with that evidence rather than around it. Clinicians and scientists trust publications, validation data, study design, and peer and institutional endorsement, and discount promotional language, so we build marketing that surfaces and communicates your evidence soberly and makes it easy to find and evaluate, within cleared claims. The marketing job is to package rigor credibly, get it in front of the right scientific and clinical audiences, and let the data lead, which is exactly how you earn trust with a buyer who evaluates like a peer reviewer.
By making the access and economic story a first-class part of the marketing, alongside the clinical one. For devices, diagnostics, and many digital-health products, coverage, reimbursement, workflow fit, and total cost can decide the deal, and the people who approve spend weigh them as heavily as efficacy. We help articulate the economic and access case, within cleared claims and in coordination with your team, so procurement and budget holders see why the product is worth adopting, not just that it works.
Yes, and in a medical context accuracy is critical, because a wrong or overstated AI answer about your product is a real problem, not just a missed opportunity. We work on the discoverable side to ensure your accurate, cleared story exists on the open web in a form the engines can cite correctly, and we build the credible mentions and clean entity data they corroborate, so assistants represent you accurately and within your claims. It is done compliance-first, in coordination with your regulatory function, so more visibility never means an overstated claim.
Evidence-led content, credibility, and AI Search compound over quarters; ABM and scientific engagement open institutional conversations within the first months; and deals close over the long, evidence-gated, multi-stakeholder cycle through validation, reimbursement, and procurement. We report against your CRM on the leading indicators that matter, target-institution engagement, qualified pipeline, and progress through the cycle, not vanity metrics. That long-cycle discipline is how our portfolio reached $30M+ in CRM-tracked marketing-led revenue and 133% SQL growth per quarter in faster segments.
Bring your offer, channels, and revenue goals. We'll show you where the biggest growth constraint is and what to build next.
For B2B tech companies selling complex expertise to serious buyers.
I’m Danylo, founder of XQL. For 9+ years I’ve helped B2B tech companies turn technical expertise into pipeline — 60+ clients and $30M+ in CRM-tracked revenue.
30 minutes, no deck. Bring your offer, channels, and revenue goals — I’ll come with a read on where your biggest growth constraint is and what to build next.
